Perrigo Company plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Perrigo Company plc (PRGO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 19.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-02-26
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 19.00K shares, a 82.88% decline from fiscal 2024.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 111.00K shares, a 38.33% decline from fiscal 2023.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 180.00K shares, a 53.85% increase from fiscal 2022.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 117.00K shares, a 21.88% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|
| 2025-12-31 | 19.00K shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 111.00K shares 10-K · filed 2026-02-26 | |
| 2023-12-31 | 180.00K shares 10-K · filed 2025-02-28 | |
| 2022-12-31 | 117.00K shares 10-K · filed 2024-02-27 | |
| 2021-12-31 | 96.00K shares 10-K · filed 2023-02-28 | |
| 2020-12-31 | 120.00K shares 10-K · filed 2022-03-01 | |
| 2019-12-31 | 43.00K shares 10-K · filed 2021-03-01 | |
| 2018-12-31 | 26.00K shares 10-K · filed 2020-02-27 | |
| 2017-12-31 | 85.00K shares 10-K · filed 2019-02-27 | |
| 2016-12-31 | 256.00K shares 10-K · filed 2018-03-01 | |
| 2015-12-31 | 2.00K shares 10-K · filed 2017-05-22 | |
| 2015-06-27 | 4.00K shares 10-KT · filed 2016-02-25 | |
| 2014-06-28 | 6.00K shares 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |